Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively.
Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier diagnosis, leading to earlier initiation of preventative therapies, can improve long-term lung health.

Here are a few of the most common diseases Tested in Pulmonary Panel:

  • Cystic Fibrosis
  • Central Hypoventilation Syndrome
  • Pulmonary arterial hypertension
  • Ret gene mutation can cause lung cancer
  • Chronic Obstructive Pulmonary disease
  • Bronchiectasis
  • Neuroendocrine Lung tumors
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis Disease
  • Pulmonary Surfactant Dysfunction
  • Interstitial Lung Disease
  • Congenital Hypoventilation Syndrome
  • Primary Ciliary
  • Dyskinesia Ciliary Dyskinesia
  • Kartagener Syndrome
  • Emphysema
  • Pneumothorax (Spontaneous Pneumothorax)
  • Pulmonary Fibrosis
  • Asthma
  • Respiratory Distress Syndrome
  • Pulmonary Hypertension
  • Serpinal Mutations can lead to AAT deficiency which is associated with a substantially increased risk of lung disease

Panels that are offered at Tesis Biosciences include:

  • Pulmonary Arterial Hypertension
  • Cystic Lung Disease
  • Lung Disorders Comprehensive